tirzepatide ppt Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Understanding and Managing MOUNJARO® Therapy

In this week's On The Pen Podcast, we're breaking down one of the biggest shifts happening in obesity medicine

Pharmacology & Therapeutics, 2007, 113(3): 546-593

2024;5:e214

Keep rehydrating with electrolytes, especially during the beginning stages of this oral treatment

The negative correlations between C4A and C4B, as well as between C4L and C4S copy numbers, more likely indicate that these loci reside at opposing ends of a risk (C4A and C4L) and protective (C4B and C4S) spectrum, existing in a state of linkage disequilibrium (143)

Beyond weight loss, GLP-1 medications improve several metabolic risk factorsincluding fasting glucose, HbA1c, and triglyceridesthat independently correlate with blood pressure